A single dose of 240 mg gentamicin during transrectal prostate biopsy significantly reduces septic complications

Urology

Volumn 82, Issue 5, 2013, Pages 998-1003

  Lorber, Gideon ^a   Benenson, Shmuel ^a   Rosenberg, Shilo ^a   Gofrit, Ofer N ^a   Pode, Dov ^a  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

CEFTRIAXONE; CIPROFLOXACIN; GENTAMICIN; OFLOXACIN;

ANTIBIOTIC PROPHYLAXIS; ARTICLE; BLOOD CULTURE; CLINICAL PROTOCOL; CONTROLLED STUDY; DRUG DOSE COMPARISON; HUMAN; HUMAN TISSUE; INFECTION PREVENTION; INFECTION RATE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE BIOPSY; RETROSPECTIVE STUDY; SINGLE DRUG DOSE; TRANSRECTAL ULTRASONOGRAPHY; URINALYSIS; UROSEPSIS;

AGED; AMINOGLYCOSIDES; ANTIBIOTIC PROPHYLAXIS; BIOPSY; FLUOROQUINOLONES; GENTAMICINS; HUMANS; MALE; MIDDLE AGED; PROSTATE; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RETROSPECTIVE STUDIES; SEPSIS;

EID: 84886949230     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2013.01.074     Document Type: Article

References (22)

1. M. Davis, M. Sofer, and S.S. Kim The procedure of transrectal ultrasound guided biopsy of the prostate: a survey of patient preparation and biopsy technique The Journal of Urology 167 2 Pt 1 2002 566 570
2. H. Sadeghi-Nejad, M. Simmons, and G. Dakwar Controversies in transrectal ultrasonography and prostate biopsy Ultrasound quarterly 22 3 2006 169 175
3. Grabe M, Bjerklund-Johansen TE, Botto H, et al. EAU Guidelines Office. The Updated EUA Guidelines on Urological Infections [updated March 2011]. Available at: http://www.uroweb.org/gls/pdf/15-Urological-Infections.pdf.
4. J.S. Wolf Jr., C.J. Bennett, and R.R. Dmochowski Best practice policy statement on urologic surgery antimicrobial prophylaxis The Journal of Urology 179 4 2008 1379 1390
5. M. Sheikh, A.Y. Hussein, and E.O. Kehinde Patients' tolerance and early complications of transrectal sonographically guided prostate biopsy: prospective study of 300 patients J Clin Ultrasound 33 9 2005 452 456
6. J. Feliciano, E. Teper, and M. Ferrandino The incidence of fluoroquinolone resistant infections after prostate biopsy-are fluoroquinolones still effective prophylaxis? The Journal of Urology 179 3 2008 952 955 discussion 5
7. O.M. Zaytoun, E.H. Vargo, and R. Rajan Emergence of fluoroquinolone- resistant Escherichia coli as cause of postprostate biopsy infection: implications for prophylaxis and treatment Urology 77 5 2011 1035 1041
8. A.A. Mosharafa, M.H. Torky, and W.M. El Said Rising incidence of acute prostatitis following prostate biopsy: fluoroquinolone resistance and exposure is a significant risk factor Urology 78 3 2011 511 514
9. K.C. Chu, R.E. Tarone, and H.P. Freeman Trends in prostate cancer mortality among black men and white men in the United States Cancer 97 6 2003 1507 1516
10. L. Carmignani, S. Picozzi, and M. Spinelli Bacterial sepsis following prostatic biopsy International Urology and Nephrology 44 4 2012 1055 1063
11. Gonzalez CM, Averch T, Boyd LA, et al. American Urological Association. White paper on the incidence, prevention and treatment of complications related to prostate needle biopsy. Available at: http://www.auanet.org/common/pdf/ practices-resources/quality/patient-safety/Prostate-Needle-Biopsy-White-Paper. pdf.
12. C.K. Naughton, D.K. Ornstein, and D.S. Smith Pain and morbidity of transrectal ultrasound guided prostate biopsy: a prospective randomized trial of 6 versus 12 cores The Journal of Urology 163 1 2000 168 171
13. M.A. Abdul-Ghani, F. Glicberg, and H. Sahagian High incidence of resistant pathogens in community acquired bacteriuria from patients in the Jerusalem area with lower urinary tract infections Harefuah 141 12 2002 1032 1035 91, 90
14. J.A. Karlowsky, D.J. Hoban, and M.R. Decorby Fluoroquinolone-resistant urinary isolates of Escherichia coli from outpatients are frequently multidrug resistant: results from the North American Urinary Tract Infection Collaborative Alliance-Quinolone Resistance study Antimicrobial Agents and Chemotherapy 50 6 2006 2251 2254
15. H. Arslan, O.K. Azap, and O. Ergonul Risk factors for ciprofloxacin resistance among Escherichia coli strains isolated from community-acquired urinary tract infections in Turkey The Journal of Antimicrobial Chemotherapy 56 5 2005 914 918
16. M.J. Newman, and A. Seidu Carriage of antimicrobial resistant Escherichia coli in adult intestinal flora West African Journal of Medicine 21 1 2002 48 50
17. A.K. Taylor, T.R. Zembower, and R.B. Nadler Targeted antimicrobial prophylaxis using rectal swab cultures in men undergoing transrectal ultrasound guided prostate biopsy is associated with reduced incidence of postoperative infectious complications and cost of care The Journal of Urology 187 4 2012 1275 1279
18. K.Y.T. Shigemura, M. Matsumoto, and S. Aradawa Can penicillin including beta-lactamase inhibitor overcome febrile complications after transrectal prostate biopsy? Journal of Urology 183 4 2010 e316
19. B. Akduman, D. Akduman, and H. Tokgoz Long-term fluoroquinolone use before the prostate biopsy may increase the risk of sepsis caused by resistant microorganisms Urology 78 2 2011 250 255
20. D. Gilbert, and J. Leggett Aminoglycosides G.L. Mandell, J.E. Bennett, R. Dolin, Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases 7th ed. 2010 Churchill Livingstone/Elsevier Philadelphia 359 384
21. M. Adibi, M.S. Pearle, and Y. Lotan Cost-effectiveness of standard vs intensive antibiotic regimens for transrectal ultrasonography (TRUS)-guided prostate biopsy prophylaxis BJU International 110 2 Pt 2 2012 E86 E91
22. R. Tal, P.M. Livne, and D.M. Lask Empirical management of urinary tract infections complicating transrectal ultrasound guided prostate biopsy The Journal of Urology 169 5 2003 1762 1765